Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Non Operating Income (2016 - 2025)

Historic Non Operating Income for iBio (IBIO) over the last 16 years, with Q4 2025 value amounting to $452000.0.

  • iBio's Non Operating Income rose 72181.82% to $452000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $736000.0, marking a year-over-year decrease of 4449.47%. This contributed to the annual value of $225000.0 for FY2025, which is 8110.83% down from last year.
  • According to the latest figures from Q4 2025, iBio's Non Operating Income is $452000.0, which was up 72181.82% from $231000.0 recorded in Q3 2025.
  • In the past 5 years, iBio's Non Operating Income ranged from a high of $9.6 million in Q2 2021 and a low of -$459000.0 during Q1 2021
  • Moreover, its 5-year median value for Non Operating Income was $41000.0 (2021), whereas its average is $570350.0.
  • In the last 5 years, iBio's Non Operating Income soared by 166350.25% in 2021 and then crashed by 36190.48% in 2023.
  • Over the past 5 years, iBio's Non Operating Income (Quarter) stood at $40000.0 in 2021, then crashed by 75.0% to $10000.0 in 2022, then dropped by 20.0% to $8000.0 in 2023, then soared by 587.5% to $55000.0 in 2024, then skyrocketed by 721.82% to $452000.0 in 2025.
  • Its Non Operating Income was $452000.0 in Q4 2025, compared to $231000.0 in Q3 2025 and $35000.0 in Q2 2025.